Ether derivatives of alkyl piperidines and pyrrolidines as antipsychotic agents

A method of inhibiting psychoses in a mammal which comprises administering to the mammal an effective amount of a compound of formula:

• ##STR17## wherein:
• n is 0, 1, or 2;
• p is 0 or 1;
• m i 1,2, or 3;
• X is --C.dbd.C-- or R.sup.1 C.dbd.CR.sup.2 (cis or trans);
• R.sup.1 and R.sup.2 independently are H, alkyl of 1-4 carbon atoms, or phenyl;
• Ar is naphthyl or phenyl, optionally substituted with 1-5 substituents individually selected form NO.sub.2, halogen, CF.sub.3, SH, alkyl of 1-4 carbon atoms, alkoxy of 1-4 carbon atoms, hydroxy alkyl of 1-4 carbon atoms, --C(.dbd.0)--R.sup.3, --NR.sup.3 R.sup.4, --C(.dbd.0)--NR.sup.3 R.sup.4, --NR.sup.3 C(.dbd.0)R.sup.4 S(O)qR.sup.5 where q is 0, 1, or 2;
• R.sup.3 and R.sup.4 independently are H, alkyl of 1-4 carbon atoms, or phenyl;
• R.sup.5 is alkyl of 1-4 carbon atoms or phenyl;
• R is H, alkyl of 1-5 carbon atoms, cycloalkyl of 3-6 carbon atoms, Arl where Arl is phenyl or naphthyl, or --CH.dbd.CR.sup.6 R.sup.7 ;
• and
• R.sup.6 and R.sup.7 independently are H or alkyl of 1-4 carbon atoms, provided that when n=0 the side chain is not located at the 2-position of the ring;
• or po1 a pharmaceutically acceptable salt thereof.